Aug 18, 2023, 17:22
New research led by Dr. Zhengping Zhuang’s team addresses the urgent need to develop new therapies for colorectal carcinoma (CRC) – NCI Neuro-Oncology Branch
NCI Neuro-Oncology Branch shared on their Twitter page:
“New research led by Dr. Zhengping Zhuang‘s team addresses the urgent need to develop new therapies for colorectal carcinoma (CRC). They found potential in TP5, a novel therapy that inhibits CDK5—an enzyme linked to CRC progression.”
For the article click here.
Source: NCI Neuro-Oncology Branch/Twitter
Aug 29, 2024, 20:47